BIOMAT Database Logo BIOMAT Database Logo

Excitation of afferent cardiac sympathetic nerve fibers induced by vagal stimulation. 1975

Y Uchida, and N Yoshimoto, and S Murao

The effect of vagal stimulation on activity of afferent sympathetic nerve fibers from the dog's left ventricle has been examined. During partial constriction of the coronary artery, a brief electrical stimulation of the cervical vagus nerves resulted in a decrease in blood flow of the constricted artery, systolic bulge of the left ventricle, elevation of the ST segment of electrocardiogram and excitation of the afferent nerve fibers, which continued for up to 15 min. These changes were not produced without coronary artery constriction. Intravenous injection of phentolamine eliminated the decrease in blood flow, and suppressed systolic bulge, elevation of the ST segment and excitation of afferent fibers. Propranolol could not eliminate the decrease in blood flow while suppressed the other changes. Atropine eliminated all of these changes. The results indicate participation of adrenergic alpha-receptors in sustained decrease of coronary blood flow and excitation of afferent cardiac sympathetic nerve fibers which can be produced by a brief vagal excitation.

UI MeSH Term Description Entries
D009475 Neurons, Afferent Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM. Afferent Neurons,Afferent Neuron,Neuron, Afferent
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Uchida, and N Yoshimoto, and S Murao
Acid-induced excitation of afferent cardiac sympathetic nerve fibers.
January 1975, The American journal of physiology,
Y Uchida, and N Yoshimoto, and S Murao
Potassium-induced excitation of afferent cardiac sympathetic nerve fibers.
March 1974, The American journal of physiology,
Y Uchida, and N Yoshimoto, and S Murao
Bradykinin-induced excitation of afferent cardiac sympathetic nerve fibers.
January 1974, Japanese heart journal,
Y Uchida, and N Yoshimoto, and S Murao
Excitation of afferent cardiac sympathetic nerve fibers during coronary occlusion.
May 1974, The American journal of physiology,
Y Uchida, and N Yoshimoto, and S Murao
Tachypnea after stimulation of afferent cardiac sympathetic nerve fibers.
April 1976, The American journal of physiology,
Y Uchida, and N Yoshimoto, and S Murao
Vagal nerve stimulation activates vagal afferent fibers that reduce cardiac efferent parasympathetic effects.
November 2015, American journal of physiology. Heart and circulatory physiology,
Y Uchida, and N Yoshimoto, and S Murao
Mechanosensitivity of afferent cardiac sympathetic nerve fibers.
May 1974, The American journal of physiology,
Y Uchida, and N Yoshimoto, and S Murao
Adenosine activates cardiac sympathetic afferent fibers and potentiates the excitation induced by coronary occlusion.
June 1995, Journal of the autonomic nervous system,
Y Uchida, and N Yoshimoto, and S Murao
[Proceedings: 383. Modality of excitation of afferent cardiac sympathetic nerve fibers during coronary occlusion (author's transl)].
January 1973, Nihon seirigaku zasshi. Journal of the Physiological Society of Japan,
Y Uchida, and N Yoshimoto, and S Murao
Excitation of afferent cardiac sympathetic nerve fibres during myocardial ischaemia.
May 1967, The Journal of physiology,
Copied contents to your clipboard!